We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$13.7B
AUM Growth
+$3.66B
Cap. Flow
+$2.6B
Cap. Flow %
18.96%
Top 10 Hldgs %
51.2%
Holding
3,395
New
1,045
Increased
548
Reduced
607
Closed
1,119

Sector Composition

Rank Sector Weight
1 Technology 8.67%
2 Consumer Discretionary 5.65%
3 Financials 5.29%
4 Healthcare 4.91%
5 Materials 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTO icon
1976
Alto Ingredients
ALTO
$340M
$39K ﹤0.01%
+14,791
New +$47.1K
LCTX icon
1977
Lineage Cell Therapeutics
LCTX
$278M
$39K ﹤0.01%
+35,923
New +$39.4K
MVIS icon
1978
Microvision
MVIS
$78.9M
$39K ﹤0.01%
+991
New +$34.1K
NKTR icon
1979
Nektar Therapeutics
NKTR
$2.58B
$39K ﹤0.01%
4,700
+2,422
+106% +$18.3K
SGMO
1980
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$39K ﹤0.01%
72,177
+20,383
+39% +$9.4K
LEV
1981
DELISTED
The Lion Electric Company
LEV
$39K ﹤0.01%
22,556
-119,713
-84% -$208K
MARK
1982
DELISTED
Remark Holdings, Inc.
MARK
$39K ﹤0.01%
+79,445
New +$39.8K
OCSAW
1983
Oculis Holding AG Warrants
OCSAW
$37K ﹤0.01%
24,969
UHGWW
1984
DELISTED
United Homes Group Warrant
UHGWW
$37K ﹤0.01%
37,497
DFNS
1985
T3 Defense Inc
DFNS
$38.3M
$36K ﹤0.01%
+13
New +$94.9K
RNWWW
1986
ReNew Energy Global PLC Warrant
RNWWW
$44.5K
$36K ﹤0.01%
33,321
+29
+0.1% +$21
GRND.WS
1987
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$36K ﹤0.01%
20,431
-989
-5% -$1.2K
AMPE
1988
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$36K ﹤0.01%
+17,962
New +$46.5K
SKYH.WS icon
1989
Sky Harbour Group Warrants
SKYH.WS
$21.4M
$35K ﹤0.01%
47,656
-100
-0.2% -$50
TLSIW icon
1990
TriSalus Life Sciences Warrant
TLSIW
$40.7M
$35K ﹤0.01%
29,931
HYZN
1991
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$34K ﹤0.01%
+780
New +$38.9K
PBLA
1992
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$34K ﹤0.01%
+1,907
New +$29.8K
MTA
1993
Metalla Royalty & Streaming
MTA
$818M
$33K ﹤0.01%
+10,965
New +$32.7K
VUZI icon
1994
Vuzix
VUZI
$224M
$33K ﹤0.01%
+15,965
New +$43.5K
BRBS icon
1995
Blue Ridge Bankshares
BRBS
$332M
$32K ﹤0.01%
+10,771
New +$32.9K
CGEN icon
1996
Compugen
CGEN
$228M
$32K ﹤0.01%
+16,218
New +$14.2K
NBP
1997
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$32K ﹤0.01%
+17,354
New +$25.9K
NOTE
1998
DELISTED
FiscalNote
NOTE
$32K ﹤0.01%
+2,391
New +$39.4K
RNXT icon
1999
RenovoRx
RNXT
$50.5M
$32K ﹤0.01%
+14,041
New +$13.4K
ISUN
2000
DELISTED
iSun, Inc. Common Stock
ISUN
$32K ﹤0.01%
+102,433
New +$21.4K

Similar funds

HRT Financial's Q4 2023 Portfolio in Review

As of Q4 2023, HRT Financial held 3,395 positions worth $13.7B, up 37% from $10B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

HRT Financial deployed $2.6B of net new capital in Q4 2023, opening 1,045 new positions and adding to 548 existing holdings. Its largest new stake was Linde: 727,095 shares worth $299M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $83.7M trimmed.

  • HRT Financial's largest Q4 2023 buy was Linde: 727,095 shares worth $299M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.94B increase.
  • HRT Financial's biggest Q4 2023 reduction was Broadcom, cutting an estimated $83.7M.
  • HRT Financial fully exited Newmont in Q4 2023, selling an estimated $140M.
  • HRT Financial's ten largest holdings make up 51% of its $13.7B portfolio in Q4 2023.
  • HRT Financial opened 1,045 new positions and closed 1,119 in Q4 2023.
  • HRT Financial's portfolio value rose 37% quarter-over-quarter to $13.7B.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.